Medicinal product name Adcetris
Pharmaceutical form Powder for concentrate for solution for infusion
Strength 50 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/12/794/001 KZSN1 Is available
Legal status Rx Prescription (Pr.)
KZS NHS Reimbursed medicines
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
Conclusion on the therapeutic and cost effectiveness of medicines Oct 6, 2021 C84.6 C84.7
 Mar 4, 2022 C84 C86
 May 18, 2022 C84.6 C84.7
 Aug 19, 2022 C81
ATC code L01FX05 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(4 containers)
Tamro N1
(50 mg)
Glass vial 3839.52 
KZS*
EU/1/12/794/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/12/794/001
Date of authorisation Oct 25, 2012
Marketing authorisation holder, country Takeda Pharma A/S, Denmark